Clinical Case of Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease in the Patient with History of Pulmonary Tuberculosis
https://doi.org/10.58838/2075-1230-2023-101-5-64-68
Abstract
The article describes the follow-up over a clinical case of the patient with COPD, pulmonary hypertension (PH), and history of pulmonary tuberculosis. According to the guidelines, treatment of the patient with PH which developed due to bronchopulmonary pathology was focused on constant bronchodilator therapy to reduce hypoxemia and to achieve additional vasodilating effect on vessels of the pulmonary circulation, as well as on non-invasive high-flow oxygen therapy which inhibited the progression of PH (it prevented mortality).
About the Authors
M. V. Moiseeva
Omsk State Medical University, Russian Ministry of Health
Russian Federation
Russian Federation
Marina V. Moiseeva, Candidate of Medical Sciences, Associate Professor of Department of Polyclinic Therapy and Internal Diseases
12, Lenina St., Omsk, 644099
Phone: + 7 (3812) 95-70-01
N. V. Bagisheva
Omsk State Medical University, Russian Ministry of Health
Russian Federation
Russian Federation
Natalia V. Bagisheva, Candidate of Medical Sciences, Associate Professor of Department of Polyclinic Therapy and Internal Diseases
12, Lenina St., Omsk, 644099
Phone: + 7 (923) 672-00-20
I. A. Viktorova
Omsk State Medical University, Russian Ministry of Health
Russian Federation
Russian Federation
Inna A. Viktorova, Doctor of Medical Sciences, Professor, Head Professor of Department of Polyclinic Therapy and Internal Diseases
12, Lenina St., Omsk, 644099
Phone: + 7 (3812) 95-70-01
A. V. Mordyk
Omsk State Medical University, Russian Ministry of Health; National Medical Research Center of Phthisiopulmonology and Infectious Diseases, Russian Ministry of Health
Russian Federation
Russian Federation
Anna V. Mordyk, Doctor of Medical Sciences, Professor, Head of Department of Phthisiology, Pulmonology and Infectious Diseases
12, Lenina St., Omsk, 644099
Phone: + 7 (3812) 95-70-01
References
1. Avdeev S.N., Barbarash O.L., Bautin A.E., Volkov A.V., Veselova T.N., Galyavich A.S. et el. Pulmonary hypertension including chronic thromboembolic pulmonary hypertension. Clinical guidelines 2020. Rossiysky Kardiologicheskiy Journal, 2021, vol. 26, no. 12, pp. 4683. (In Russ.) https://doi.org/10.15829/1560-4071-2021-4683
2. Avdeev S.N., Gaynitdinova V.V., Tsareva N.A., Merzhoeva Z.M. Impact of pulmonary hypertension on the of the course and prognosis in patients with chronic obstructive pulmonary disease. RKZh, 2018, no. 6, pp. 173-178. (In Russ.)
3. Antonov V.N., Ignatova G.L., Rodionova O.V., Grebneva I.V., Blinova E.V., Pustovalova I.A., Drozdov I.V. The contribution of hypertension to the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease. Sovremennye Problemy Nauki i Obrazovaniya, 2014. Available: https://science-education.ru/ru/article/view?id=14963 Accessed September 21, 2003.
4. Bagisheva N.V., Mordyk A.V., Trukhan D.I., Viktorova I.A., Moiseeva M.V. Тherapy сorrection of concerned chronic heart failure and chronic obstructive pulmonary disease in a patient with first identified pulmonary tuberculosis. Case report. Consilium Medicum, 2022, vol. 24, no. 3, pp.157–159. (In Russ.) https://doi.org/10.26442/20751753.2022.3.201525
5. Karoli N.A., Borodkin A.V., Rebrov A.P. Features of the clinic and diagnosis of chronic heart failure in patients with chronic obstructive pulmonary disease. Kardiologia, 2019, vol. 59, no. 2, pp. 25-30. (In Russ.)
6. Mordyk A.V., Bagisheva N.V., Viktorova I.A., Moiseeva M.V., Goloshubina V.V., Filipenko G.V., Aroyan A.R., Stativka E.A. Evaluation of the efficacy of pharmacotherapy for cardiovascular comorbid pathology in patients with newly detected pulmonary tuberculosis in the background of COPD. Sovremennye Problemy Nauki i Obrazovaniya, 2022, no. 3, pp. 104. (In Russ.)
7. Mordyk A.V., Bagisheva N.V., Viktorova I.A., Moiseeva M.V., Sitnikova S.V., Aroyan A.R., Batischeva T.L. The role and place of bronchodilator and anti-inflammatory therapy for chronic obstructive pulmonary disease in patients with new respiratory tuberculosis. Meditsinsky Alyans, 2022, vol. 10, no. 2, pp. 12-18. (In Russ.)
8. Oganov R.G., Denisov I.N., Simanenkov V.I. Comorbid pathology in clinical practice. Guidelines. Kardiovaskulyarnaya Terapiya i Profilaktika, 2017, vol. 6, no. 16, pp. 5-56. (In Russ.)
9. Chazova I.E., Nevzorova V.A., Ambatiello L.G. Clinical practice guidelines on the diagnosis and treatment of patients with arterial hypertension and chronic obstructive pulmonary disease. Systemnye Gipertenzii, 2020, vol. 17, no. 3, pp. 7-34. (In Russ.) https://doi.org/10.26442/2075082X.2020.3.200294.
10. Khronicheskaya obstruktivnaya bolezn legkikh. Klinicheskiye rekomendatsii. [Chronic obstructive lung disease. Guidelines]. Moscow, RRO Publ., 2021, 94 p.
11. 2020 Clinical practice guidelines for chronic heart failure. Rossiysky Kardiologicheskiy Journal, 2020, vol, 25, no. 11, pp. 4083. (In Russ.) https://doi.org/10.15829/1560-4071-2020-4083
12. Nathan S., Barbera J., Gaine S., Harari S., Martinez F., Olschewski H., Olsson K., Peacock A., Pepke-Zaba J., Provencher S., Weissmann N., Seeger W. Pulmonary hypertension in chronic lung disease and hypoxia. Eur. Respir., 2019, vol. 53, no. 1, pp.1801914. https://doi.org/10.1183/13993003.01914-2018
13. Gredic M., Blanco I., Kovacs G., Helyes Z., Ferdinandy P., Olschewski H., Albert Barberà J., Weissmann N. Pulmonary hypertension in chronic obstructive pulmonary disease. Br. J. Pharmacol., 2021, vol. 178, no. 1, pp.132-151. https://doi.org/10.1111/b.14979
14. Cassady S., Reed R. Pulmonary Hypertension in COPD: A Case Study and Review of the Literature. Medicina (Kaunas), 2019, vol.55, no. 8, pp. 432. https://doi.org/10.3390/medicina55080432
Review
For citations:
Moiseeva M.V., Bagisheva N.V., Viktorova I.A., Mordyk A.V. Clinical Case of Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease in the Patient with History of Pulmonary Tuberculosis. Tuberculosis and Lung Diseases. 2023;101(5):64-68. (In Russ.) https://doi.org/10.58838/2075-1230-2023-101-5-64-68
Views:
225
Email this article 